BIOCE. NEW 2023 DL-,0001
BIOCE. NEW 2023 DL-,0001
Action · US09072V6002 · BIOC · A3EG0A (XNCM)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - - - -3,21 % -1,00 % -99,96 %

Profil de l'entreprise pour BIOCE. NEW 2023 DL-,0001 Action

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Données de l'entreprise

Nom BIOCE. NEW 2023 DL-,0001
Société Biocept, Inc.
Symbole BIOC
Site web https://biocept.com
Marché d'origine XNCM Frankfurt
WKN A3EG0A
ISIN US09072V6002
Type de titre Action
Secteur Healthcare
Industrie Medical - Diagnostics & Research
PDG Mr. Darrell Taylor Esq.
Pays États-Unis d'Amérique
Devise EUR
Employés 0,1 T
Adresse 9955 Mesa Rim Road, 92121 San Diego
Date d'introduction en bourse 2014-02-05

Symboles boursiers

Nom Symbole
NASDAQ BIOC

Autres actions

Les investisseurs qui détiennent BIOCE. NEW 2023 DL-,0001 ont également les actions suivantes dans leur portefeuille :
Goldman Sachs ETF Trust Goldman Sachs Dynamic New York Municipal Income ETF
Goldman Sachs ETF Trust Goldman Sachs Dynamic New York Municipal Income ETF ETF
UNICREDIT 22/28 FLR MTN
UNICREDIT 22/28 FLR MTN Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025